Related Experiment Video
Updated: Jul 15, 2025

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
Published on: May 27, 2016
Comparative study on ABCB1-dependent efflux of anthracyclines and their metabolites: consequences for cancer
Kamil Piska1, Paulina Koczurkiewicz-Adamczyk1, Marek Jamrozik2
1Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.
Abstract:
1. ABCB1 (P-glycoprotein, MDR1) is one of the most important transporter involved in cancer multi-drug resistance. It also plays a significant role in cancer resistance against anthracyclines, an anticancer group of drugs, including doxorubicin and daunorubicin. Several intracellular enzymes metabolise anthracyclines to carbonyl-reduced, hydroxy metabolites, which have impaired cytotoxic properties. However, metabolite efflux by ABCB1 transporter is not well characterised, while it may be the mechanism responsible for the metabolites' lack of activity.2. In this study recombinant ABCB1 ATPase transporter assay; anthracyclines accumulation assay in resistant cells overexpressing ABCB1; and molecular modelling were used to investigate anthracyclines: doxorubicin and daunorubicin and their carbonyl-reduced metabolites (doxorubicinol, daunorubicinol) susceptibility for ABCB1-dependent efflux.3. Based on the kinetics parameters of ATPase activity of ABCB1, it was found that daunorubicinol exerted an exceptionally high potential for being effluxed by the ABCB1 transporter. ABCB1 significantly affected the accumulation pattern of studied chemicals in resistant cancer cells. Doxorubicin and daunorubicinol accumulation were influenced by the activity of ABCB1 modulator - valspodar.4. Results indicate that ABCB1 activity affects not only anthracyclines but also their metabolites. Therefore crosstalk between the process of anthracyclines metabolism and metabolite efflux may be the mechanism of impairing anticancer properties of anthracyclines metabolites.
Insights
ABCB1 transporter effluxes anthracyclines and their metabolites, like daunorubicinol. This efflux impacts drug accumulation in resistant cancer cells, potentially explaining reduced anticancer efficacy.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- ABCB1 (P-glycoprotein, MDR1) is crucial in cancer multidrug resistance, particularly against anthracyclines like doxorubicin.
- Intracellular metabolism of anthracyclines yields less active metabolites, but their efflux by ABCB1 is poorly understood.
Purpose of the Study:
- To investigate the susceptibility of anthracyclines (doxorubicin, daunorubicin) and their metabolites (doxorubicinol, daunorubicinol) to ABCB1-dependent efflux.
- To elucidate the role of ABCB1 in the accumulation and activity of these compounds in resistant cancer cells.
Main Methods:
- Recombinant ABCB1 ATPase transporter assays.
- Anthracycline accumulation assays in ABCB1-overexpressing resistant cells.
- Molecular modeling studies.
Main Results:
- Daunorubicinol showed a high potential for ABCB1-mediated efflux.
- ABCB1 activity significantly altered the accumulation of doxorubicin and daunorubicinol in resistant cells.
- Valspodar, an ABCB1 modulator, influenced the accumulation of doxorubicin and daunorubicinol.
Conclusions:
- ABCB1-mediated efflux affects both anthracyclines and their metabolites.
- The interplay between anthracycline metabolism and metabolite efflux by ABCB1 may diminish their anticancer properties.
More Related Videos
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
Related Concept Videos
ABC Transporters: Exporter
Treatment Resistant Cancers
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Hepatic Drug Clearance: Role of Transporters